Stat3 pathway inhibitors and cancer stem cell inhibitors
US8877803B2 · kind B2 · utility
6Cited by
2References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 10, 2008 |
| Grant date | Nov 4, 2014 |
| Priority date | — |
| Expiry date | Dec 10, 2031 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel naphtho class of compounds as Stat3 pathway inhibitors and as cancer stem cell inhibitors; to methods of using such compounds to treat cancer; to methods of using such compounds to treat disorders in a mammal related to aberrant Stat3 pathway activity; to pharmaceutical compositions containing such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.